CATALYST FINANCIAL PARTNERS LLC

Position in MRK — Merck & Co., Inc.

CIK 1927537 BOSTON, MA

Position in MRK

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$2,596,342

+$284,609 QoQ

Shares Held

20,205

+5.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.51%

of 13F equity value

Holder Rank

#1,429

of 3,769 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CATALYST FINANCIAL PARTNERS LLC holds $23,806,391 across 9 Drug Manufacturers - General names. MRK ranks #4 (10.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,449	$7,735,124
2	JNJ	Johnson & Johnson	24,867	$6,315,471
3	ABBV	AbbVie Inc.	15,393	$3,873,494
4	MRK	Merck & Co., Inc. This page	20,205	$2,596,342
5	AMGN	Amgen Inc	3,386	$1,226,138
6	GILD	Gilead Sciences, Inc.	5,716	$722,159
7	PFE	Pfizer Inc	25,150	$605,612
8	BMY	Bristol Myers Squibb Co	8,894	$512,472

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,596,342	20,205	+5.1%	Shares	Sole	2026-07-30
2026-03-31	$2,311,733	19,218	+9.2%	Shares	Sole	2026-05-12
2025-12-31	$1,851,628	17,591	+15.7%	Shares	Sole	2026-02-04
2025-09-30	$1,275,736	15,200	+3.6%	Shares	Sole	2025-11-12
2025-06-30	$1,161,514	14,673	+6.6%	Shares	Sole	2025-08-14
2025-03-31	$1,235,366	13,763	-16.7%	Shares	Sole	2025-05-02
2024-12-31	$1,644,205	16,528	-2.5%	Shares	Sole	2025-01-30
2024-09-30	$1,925,977	16,960	-4.2%	Shares	Sole	2024-10-28
2024-06-30	$2,190,641	17,695	+0.5%	Shares	Sole	2024-07-25
2024-03-31	$2,322,583	17,602	-1.8%	Shares	Sole	2024-04-23
2023-12-31	$1,954,837	17,931	-6.4%	Shares	Sole	2024-02-07
2023-09-30	$1,972,316	19,158	+7.3%	Shares	Sole	2023-10-26
2023-06-30	$2,060,173	17,854	+10.8%	Shares	Sole	2023-08-02
2023-03-31	$1,714,262	16,113	+101.6%	Shares	Sole	2023-04-11
2022-12-31	$886,601	7,991	—	Shares	Sole	2023-01-19
No filing history on record for this holder in this stock.